Knockoff copies of Novo’s popular weight loss medicine Wegovy have held back U.S. sales despite new marketing efforts by the drugmaker.Novo Nordisk on Tuesday substantially cut its financial forecasts for the year as cheap, knockoff versions of its popular obesity drug Wegovy continue to hold back the pharmaceutical company’s growth.The Danish drugmaker now expects sales […]
